New Cancer Treatments Program
Cancer Therapeutics Program
This program works to find new ways to treat cancers like bladder and breast cancer, bringing discoveries from the lab directly to patients through clinical trials.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11178764 on NIH RePORTER |
What this research studies
This program at UC Davis focuses on finding better treatments for cancers like bladder and breast cancer. Our goal is to discover new ways to identify cancer and develop innovative medicines, moving promising ideas from the lab into clinical trials for patients. We are creating new tools for finding cancer markers, designing advanced anti-cancer drugs, and exploring new ways to deliver these medicines effectively. Our team of experts is dedicated to turning scientific breakthroughs into real-world treatments that can help you.
Who could benefit from this research
Good fit: Patients with bladder cancer, breast cancer, or other cancers who may be eligible for future clinical trials stemming from this research could potentially benefit.
Not a fit: Patients not participating in clinical trials or whose cancer types are not directly addressed by the specific agents developed may not directly benefit from this program.
Why it matters
Potential benefit: If successful, this program could lead to new and more effective treatments for various cancers, improving patient outcomes.
How similar studies have performed: This program builds on existing knowledge in drug discovery and clinical translation, with some agents already in pre-IND stages, indicating prior success in related areas.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Lam, Kit S — University of California at Davis
- Study coordinator: Lam, Kit S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.